BAKER BROS ADVISORS LLC Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for May 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 98.68 | 10,514 | 1,037,522 | 10,514 | |
| May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | P | 102.55 | 1 | 103 | 29,313,198 | 29.3 M to 29.3 M (0.00 %) |
| May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Buy | P | 102.55 | 1 | 103 | 2,849,431 | 2.8 M to 2.8 M (0.00 %) |
| May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,282 | 0 | 29,313,197 | 29.3 M to 29.3 M (0.00 %) |
| May 28 2020 | INCY | INCYTE CORP | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,282 | 0 | 2,849,430 | 2.8 M to 2.8 M (+0.05 %) |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 160.33 | 3,171 | 508,406 | 3,171 | |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,335 | 0 | 43,290,171 | 43.3 M to 43.3 M (0.00 %) |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,335 | 0 | 4,084,186 | 4.1 M to 4.1 M (+0.03 %) |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 160.00 | 1,602,312 | 256,369,920 | 43,288,836 | 44.9 M to 43.3 M (-3.57 %) |
| May 19 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 160.00 | 147,688 | 23,630,080 | 4,082,851 | 4.2 M to 4.1 M (-3.49 %) |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,189 | 0 | 7,846,213 | 7.8 M to 7.8 M (+0.02 %) |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 1,189 | 0 | 998,953 | 997.8 K to 999 K (+0.12 %) |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 3,468 | 0 | 7,845,024 | 7.8 M to 7.8 M (+0.04 %) |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Grant | A | 0.00 | 3,468 | 0 | 997,764 | 994.3 K to 997.8 K (+0.35 %) |
| May 18 2020 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 1,465,603 | 0 | 10,302,952 | |
| May 18 2020 | KNSA | Kiniksa Pharmaceut ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 0.00 | 134,397 | 0 | 1,050,440 | |
| May 12 2020 | ZYME | Zymeworks Inc. | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 35.49 | 9,000 | 319,410 | 9,000 | |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 158.50 | 457,803 | 72,561,776 | 44,891,148 | 45.3 M to 44.9 M (-1.01 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 158.50 | 42,197 | 6,688,225 | 4,230,539 | 4.3 M to 4.2 M (-0.99 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 166.16 | 4,343 | 721,610 | 45,348,951 | 45.4 M to 45.3 M (-0.01 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 166.16 | 400 | 66,462 | 4,272,736 | 4.3 M to 4.3 M (-0.01 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.96 | 48,880 | 8,063,118 | 45,353,294 | 45.4 M to 45.4 M (-0.11 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.96 | 4,505 | 743,133 | 4,273,136 | 4.3 M to 4.3 M (-0.11 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.19 | 84,663 | 13,901,157 | 45,402,174 | 45.5 M to 45.4 M (-0.19 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.19 | 7,805 | 1,281,534 | 4,277,641 | 4.3 M to 4.3 M (-0.18 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 163.41 | 16,159 | 2,640,610 | 45,486,837 | 45.5 M to 45.5 M (-0.04 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 163.41 | 1,489 | 243,324 | 4,285,446 | 4.3 M to 4.3 M (-0.03 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 166.62 | 41,072 | 6,843,564 | 45,502,996 | 45.5 M to 45.5 M (-0.09 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 166.62 | 3,786 | 630,837 | 4,286,935 | 4.3 M to 4.3 M (-0.09 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 165.70 | 91,613 | 15,180,641 | 45,544,068 | 45.6 M to 45.5 M (-0.20 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 165.70 | 8,444 | 1,399,205 | 4,290,721 | 4.3 M to 4.3 M (-0.20 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.60 | 178,862 | 29,440,041 | 45,635,681 | 45.8 M to 45.6 M (-0.39 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.60 | 16,485 | 2,713,372 | 4,299,165 | 4.3 M to 4.3 M (-0.38 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.06 | 45,606 | 7,482,107 | 45,814,543 | 45.9 M to 45.8 M (-0.10 %) |
| May 08 2020 | SGEN | SEATTLE GENETICS I ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 164.06 | 4,204 | 689,707 | 4,315,650 | 4.3 M to 4.3 M (-0.10 %) |
| May 07 2020 | NLTX | Neoleukin Therapeu ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 12.84 | 25,000 | 321,000 | 25,000 |